News | Quality Assurance (QA) | October 18, 2018

IBA Dosimetry Launches myQA Daily

myQA Daily is optimized for daily QA workflow efficiency.

myQA Daily from IBA Dosimetry enables fast as well as high-quality daily linac QA. More measurement points allow more accurate morning checks and trend analysis. It is a solution for daily Linac QA to combine workflow efficiency with high-quality measurements and analysis. With 125 ionization chambers overall, and 31 ionization chambers for each centerline, the detector array provides the largest amount of measured beam data of any available daily QA device. This increased data capacity allows a more accurate morning QA and trend analysis of dose output, flatness, symmetry, center, field size, and energy. With the higher accuracy of myQA Daily, negative trends and linac issues can be detected before the linac fails.

myQA Daily is optimized for daily QA workflow efficiency. From detector setup to measurement to test result, the entire morning QA can be completed in less than 5 minutes.

The myQA Daily software is operated easily in a web browser from any workstation or tablet PC connected to the hospital network. The server-based software enables easy integration with existing IT infrastructure.

The detector array’s real-time Wi-Fi data exchange and rechargeable battery allow wireless daily QA setup and measurements. The cable-free design enables a convenient workflow and easy use at multiple linacs.

For more information: www.iba-dosimetry.com

Related Content

MD Anderson and Varian Partner to Optimize Radiation Oncology Treatment
News | Treatment Planning | October 18, 2019
The University of Texas MD Anderson Cancer Center and Varian announced a new strategic collaboration to develop an...
Low four-year rates of gastrointestinal (13.6 percent) and urologic issues (7.6 percent) suggest hypofractionated proton therapy as an alternative to traditional radiotherapy to reduce toxicity.

Low four-year rates of gastrointestinal (13.6 percent) and urologic issues (7.6 percent) suggest hypofractionated proton therapy as an alternative to traditional radiotherapy to reduce toxicity.

Feature | Prostate Cancer | October 16, 2019 | By Jeff Zagoudis
Radiation therapy is an important tool in the clinician’s armamentarium for treatment of localized, early-stage prost
Videos | Radiation Oncology | October 11, 2019
Lorraine Drapek, DNP, nurse practitioner, radiation oncology, GI service,...
Patient Treatments With ViewRay's MRIdian Linac Begin in New England
News | Image Guided Radiation Therapy (IGRT) | October 08, 2019
ViewRay Inc. announced today that patient treatments are scheduled to begin in Boston with ViewRay's MRIdian Linac...
ProTom International received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Radiance 330 proton therapy system
News | Proton Therapy | October 07, 2019
ProTom International received 510(k) clearance from the U.S.
Attendees of ASTRO 2019 walked the halls of McCormick Place in Chicago, Ill.

Attendees of ASTRO 2019 walked the halls of McCormick Place in Chicago, Ill.

Feature | ASTRO | October 03, 2019 | By Greg Freiherr
At the American Society for Radiation Oncology’s (ASTRO) 2019 a
Videos | Prostate Cancer | September 30, 2019
Bill Hartsell, M.D., medical director of the Northwestern Medicine Proton Center in Warrenville, Ill., discusses the
AI Accurately Predicts Radiotherapy Side Effects for Head and Neck Cancer Patients
News | Artificial Intelligence | September 26, 2019
For the first time, a sophisticated computer model has been shown to accurately predict two of the most challenging...